The year's new drugsbiologics 2015 - part II:Trends and highlights that marked a complicated year
| Autor: | Coia Dulsat, Elisabet Cruces, M. Tracy, Ann I. Graul |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Biological Products Orphan Drug Production business.industry United States Food and Drug Administration Drug Costs United States Priority review Orphan drug Voucher 03 medical and health sciences 030104 developmental biology Pharmaceutical Preparations Drug Discovery Medicine Humans Marketing business Drug pricing Drug industry Drug Approval health care economics and organizations |
| Zdroj: | Drugs of today (Barcelona, Spain : 1998). 52(2) |
| ISSN: | 1699-3993 |
| Popis: | This eagle's-eye overview of the drug industry in 2015 provides insight into some of last year's top stories, including drug pricing, orphan drug development, the FDA's priority review voucher system, pipeline attrition, and the ongoing movement in M&A. We also take a look into the crystal ball and anticipate the new drugs that may reach the market in 2016. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|